InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by HASTINGS DAVID C, Director. Director active across 2 companies, notably Entasis Therapeutics Holdings Inc.. Cumulatively, 3 reports have been recorded. The latest transaction was disclosed on 17 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
010,000 shares0
Common Stock
SEC:0001209191-22-038666:0·
027,500 shares0
Common Stock
SEC:0001104659-22-005412·
027,500 shares0
Common Stock
SEC:0001104659-22-005412:0·
3 of 3 declarations
About HASTINGS DAVID C
David C. Hastings is a Director at Entasis Therapeutics Holdings Inc. and SCYNEXIS INC. In this role, he participates in the strategic decisions of these companies and ensures good governance. His experience in the biopharmaceutical sector allows him to provide valuable insights during board discussions.
